Further, the IL4I1 expression levels correlated positively with GOT1, LAP3, ALDH7A1, and ALDH9A1 in 1169 DLBCL patients (Figure 3D), suggesting that IL4I1 positively regulates key genes known to regulate drug resistance. The gene discussed is ALDH9A1; the disease is diffuse large B-cell lymphoma.